Search results
Showing 316 to 330 of 1003 results for public health medicine & health
Awaiting development Reference number: GID-TA11200 Expected publication date: TBC
Pembrolizumab with chemoradiation for untreated high-risk advanced cervical cancer [TSID10690]
Awaiting development Reference number: GID-TA11073 Expected publication date: TBC
Awaiting development Reference number: GID-TA11219 Expected publication date: TBC
Awaiting development Reference number: GID-TA11048 Expected publication date: TBC
Tislelizumab for untreated unresectable hepatocellular carcinoma [TSID10683]
Awaiting development Reference number: GID-TA11053 Expected publication date: TBC
Awaiting development Reference number: GID-TA11751 Expected publication date: TBC
Awaiting development Reference number: GID-TA11671 Expected publication date: TBC
Awaiting development Reference number: GID-TA11858 Expected publication date: TBC
Awaiting development Reference number: GID-TA11517 Expected publication date: TBC
Tasimelteon for treating sleep disturbance associated with Smith-Magenis syndrome [TSID12191]
Awaiting development Reference number: GID-TA11746 Expected publication date: TBC
Camlipixant for treating refractory or unexplained chronic cough [ID6722]
Awaiting development Reference number: GID-TA11707 Expected publication date: TBC
Sutimlimab for treating haemolytic anaemia in people with cold agglutinin disease [ID6673]
Awaiting development Reference number: GID-TA11892 Expected publication date: TBC
Rehabilitation for chronic neurological disorders including acquired brain injury (NG252)
This guideline covers rehabilitation in all settings for children, young people and adults with a chronic neurological disorder, neurological impairment or disabling neurological symptoms due to acquired brain injury, acquired spinal cord injury, acquired peripheral nerve disorder, functional neurological disorder or progressive neurological disease.
Show all sections
Sections for NG252
- Overview
- Designing and commissioning rehabilitation services
- Assessing rehabilitation needs and goal setting
- Rehabilitation planning and delivery
- Information, advice and learning as part of rehabilitation
- Rehabilitation to maintain, improve or support function
- Rehabilitation to support education, work, social and leisure activities, relationships and sex
- Terms used in this guideline
This guideline covers diagnosing and managing epilepsy in children, young people and adults in primary and secondary care, and referral to tertiary services. It aims to improve diagnosis and treatment for different seizure types and epilepsy syndromes, and reduce the risks for people with epilepsy.
Show all sections
Sections for NG217
- Overview
- 1 Diagnosis and assessment of epilepsy
- 2 Information and support
- 3 Referral to tertiary specialist services
- 4 Principles of treatment, safety, monitoring and withdrawal
- 5 Treating epileptic seizures in children, young people and adults
- 6 Treating childhood-onset epilepsies
- 7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures
Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]
In development Reference number: GID-TA11025 Expected publication date: 10 February 2027